Abstract

Centrosome cycle studies reveal promising candidates for anti-cancer drug design.

Highlights

  • Given the correlation between centrosome number and tumor progression, molecules regulating centrosomal duplication at the G1/S transition have been under considerable scrutiny

  • CaMKII is likely triggered in response to the periodic calcium oscillations that occur at the G1/S transition and are required for centrosome duplication

  • Hannak et al employed an RNAi strategy to query the role of Caenorhabditis elegans Aurora A during the first embryonic cell division (J Cell Biol 2001, 155:11091116)

Read more

Summary

Introduction

Given the correlation between centrosome number and tumor progression, molecules regulating centrosomal duplication at the G1/S transition have been under considerable scrutiny. Fisk and Winey recently used a culturebased assay of centrosome duplication to query the relevance of mMps-1p, the mouse orthologue of the Saccharomyces cerevisiae MPS1p protein kinase, a protein known to regulate spindle pole body replication (Cell 2001, 106:95-104). Matsumoto and Maller have demonstrated that, in the context of S-phase-arrested Xenopus extracts, it is calcium/calmodulin-dependent kinase (CaMKII), and not CDK2, that initiates centrosomal duplication (Science 2002, 295:499-502).

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.